Viewing Study NCT05253729



Ignite Creation Date: 2024-05-06 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 2:25 PM
Study NCT ID: NCT05253729
Status: COMPLETED
Last Update Posted: 2022-02-24
First Post: 2022-01-24

Brief Title: Efficacy of Focused Shockwave Therapy in Patients With CTS
Sponsor: Mahidol University
Organization: Mahidol University

Study Overview

Official Title: Efficacy of Focused Shockwave Therapy in Patients With Moderate to Severe Carpal Tunnel Syndrome a Single-blinded Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Carpal tunnel syndrome CTS is the most common entrapment of upper extremity Patients with CTS will experience symptoms of pain numbness of tingling sensation along the median nerve distribution In more severe case patients may have difficult manipulating objects that disturb function and patients quality of life Extracorporeal Shockwave Therapy ESWT is one of physical modalities that uses to treat many musculoskeletal disorders For CTS previous evidence showed that ESWT can improve symptoms function as well as electrophysiologic parameters However standardized guidelines as well as the study in patients with moderate to severe CTS has not been established Thus the objective of the present study was to evaluate efficacy of ESWT in term of symptoms function electrophysiologic parameters as well as sonography of median nerve in patients with moderate to severe CTS
Detailed Description: The present study was a single-blinded randomized controlled trial comparing the efficacy of focused ESWT F-ESWT to conservative treatment in patients with CTS
24 patients who was diagnosed as CTS based on symptoms of CTS and physical examination They were randomly allocated into two groups 21 patients per group mainly F-ESWT plus conservative treatment and conservative treatment only
Outcome measures were BCTQ including symptom and function subscales electrophysiologic parameters and sonography to evaluate cross-sectional area CSA of the median nerve All measures were recorded at baseline 3 weeks and 6 weeks of treatment
Statistical analysis was performed to determine changes within the same group and compare difference between the two groups

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None